EU Joint Regulatory Assessment Project Bears Fruit In COVID-19
Four more agencies are seeking to join ICMRA
The European Medicines Agency has reported progress with a collaborative project that involves other regulators in its assessments of COVID-19 products, and with the EU Medicines for All initiative for evaluating products for non-EU markets.
You may also be interested in...
Regulatory reliance and work-sharing are becoming increasingly popular as a way of avoiding duplication and speeding up drug and vaccine assessments, but while there are many benefits, regulators should also be aware of some potential pitfalls, delegates at the TOPRA annual symposium heard this week.
A new evaluation route that the European Medicines Agency launched last year came at the right time for Takeda’s dengue vaccine candidate.
Coronavirus Notebook: Regulators To Work Together On Vaccine Evaluation, AstraZeneca In Russia Link-Up
Collaboration is a key theme of this latest Pink Sheet round-up of COVID-19 news.